{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T09:00:03Z","timestamp":1775206803634,"version":"3.50.1"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T00:00:00Z","timestamp":1695686400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T00:00:00Z","timestamp":1695686400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>With the advent of direct acting antivirals, the World Health Organisation proposed eliminating Hepatitis C as a public health threat by 2030. To achieve this, countries need to diagnose, engage in care and treat their undiagnosed populations. This will require sensitisation campaigns. However previous media campaigns have had mixed impact. We conducted a scoping review to identify and understand the impact of previous Hepatitis C media campaigns. These findings could inform the delivery of future campaigns.\n<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We searched five electronic databases for published literature on media campaigns conducted for Hepatitis C awareness, testing, and treatment in Organisation for Economic Co-operation and Development (OECD) countries since 2010. Two independent reviewers screened citations for inclusion. Additionally, we spoke to stakeholders in the Hepatitis C field in the UK and conducted a Google search to identify any unpublished literature. A quantitative synthesis was conducted to identify targeted populations, strategies and media used, aims and impact of the campaigns.\n<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A title and year of publication screening of 3815 citations resulted in 113 papers that had a full abstract screen. This left 50 full-text papers, 18 were included of which 9 (50%) were from Europe. 5 (27.8%) of campaigns targeted minority ethnicities, and 9 (50%) aimed to increase testing. A Google search identified 6 grey literature sources. Most campaigns were not evaluated for impact. Discussions with stakeholders identified several barriers to successful campaigns including lack of targeted messaging, stigmatising or accusatory messaging, and short-lived or intermittent campaign strategies.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Future campaigns will likely need to be multifaceted and have multiple tailored interventions. Campaigns will need to be sizeable and robust, integrated into health systems and viewed as an ongoing service rather than one-offs.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12879-023-08603-3","type":"journal-article","created":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T12:02:45Z","timestamp":1695729765000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["A scoping review of media campaign strategies used to reach populations living with or at high risk for Hepatitis C in high income countries to inform future national campaigns in the United Kingdom"],"prefix":"10.1186","volume":"23","author":[{"given":"David","family":"Etoori","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica","family":"Desai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sema","family":"Mandal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Rosenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline A","family":"Sabin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,9,26]]},"reference":[{"key":"8603_CR1","unstructured":"WHO. Global health sector strategies on, respectively, HIV, viral hepatitis, and sexually transmitted infections for the period 2022\u20132030. 2022. Available from: https:\/\/www.who.int\/publications\/i\/item\/9789240053779."},{"issue":"24","key":"8603_CR2","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.4254\/wjh.v7.i24.2543","volume":"7","author":"J Fung","year":"2015","unstructured":"Fung J. Era of direct acting antivirals in chronic hepatitis C: who will benefit? World J Hepatol. 2015;7(24):2543\u201350.","journal-title":"World J Hepatol"},{"issue":"2","key":"8603_CR3","doi-asserted-by":"crossref","first-page":"135965352210831","DOI":"10.1177\/13596535221083179","volume":"27","author":"H Razavi","year":"2022","unstructured":"Razavi H. Polaris observatory-supporting informed decision-making at the national, regional, and global levels to eliminate viral hepatitis. Antivir Ther. 2022;27(2):13596535221083180.","journal-title":"Antivir Ther"},{"key":"8603_CR4","unstructured":"HCV Countries Dashboard \u2013 CDA Foundation. Available from: https:\/\/cdafound.org\/polaris-countries-dashboard\/. [Cited 2023 Aug 8]."},{"key":"8603_CR5","unstructured":"London Joint Working Group. Routemap to eliminating hepatitis C in London. 2020. Available from: http:\/\/ljwg.org.uk\/wp-content\/uploads\/2020\/03\/Routemap-to-eliminating-hepatitis-C-in-London-March-2020-1.pdf. [cited 2022 Dec 9]."},{"key":"8603_CR6","unstructured":"Home - London Joint Working Group. Available from: http:\/\/ljwg.org.uk\/. [Cited 2022 Dec 9]."},{"key":"8603_CR7","unstructured":"UKHSA, Hepatitis. C in England 2022: working to eliminate hepatitis C as a public health problem; 2022. Available from: https:\/\/assets.publishing.service.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/1057271\/HCV-in-England-2022-full-report.pdf. [Cited 2023 Sep 19]."},{"issue":"4","key":"8603_CR8","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1177\/1524839910386901","volume":"13","author":"SM Noar","year":"2012","unstructured":"Noar SM. An Audience\u2013Channel\u2013Message\u2013evaluation (ACME) framework for health communication campaigns. Health Promot Pract. 2012;13(4):481\u20138.","journal-title":"Health Promot Pract"},{"key":"8603_CR9","unstructured":"Public Health England. Eliminate hepatitis B and C resource summary: Hepatitis B and C testing and treatment awareness campaign. 2019. Available from: https:\/\/sexualhealth.cht.nhs.uk\/fileadmin\/sexualHealth\/contentUploads\/Documents\/PHE_Eliminate_hepatitis_B_and_C_resource_summary_July_2019_V8.pdf."},{"key":"8603_CR10","unstructured":"NHS, Face It. Hepatitis C awareness. 2007. Available from: https:\/\/www.nhs.uk\/Livewell\/hepatitisc\/Documents\/Alternative-Face-Your-Past-Booklet-in-full---FINAL.pdf. [Cited 2022 Dec 9]."},{"key":"8603_CR11","unstructured":"Department of Health. FaCe It Campaign Resource Request Form. 2008. Available from: https:\/\/www.nhs.uk\/Livewell\/hepatitisc\/Documents\/FaCe%20It%20Campaign%20Resource%20Request%20Form%202008.pdf. [Cited 2022 Dec 9]."},{"issue":"1","key":"8603_CR12","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/1364557032000119616","volume":"8","author":"H Arksey","year":"2005","unstructured":"Arksey H, O\u2019Malley L. Scoping studies: towards a methodological framework. Int J Soc Res Methodol. 2005;8(1):19\u201332.","journal-title":"Int J Soc Res Methodol"},{"issue":"1","key":"8603_CR13","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1515\/jtim-2017-0007","volume":"5","author":"A Geddawy","year":"2017","unstructured":"Geddawy A, Ibrahim YF, Elbahie NM, Ibrahim MA. Direct acting anti-hepatitis C virus drugs: clinical pharmacology and future direction. J Transl Intern Med. 2017;5(1):8\u201317.","journal-title":"J Transl Intern Med"},{"key":"8603_CR14","unstructured":"OECD. In: Wikipedia [Internet]. 2022 [cited 2022 Dec 9]. Available from: https:\/\/en.wikipedia.org\/w\/index.php?title=OECD&oldid=1125817875"},{"issue":"3","key":"8603_CR15","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1093\/fampra\/cmq006","volume":"27","author":"CW Helsper","year":"2010","unstructured":"Helsper CW, van Essen GA, Bonten MJM, de Wit NJ. A support programme for primary care leads to substantial improvements in the effectiveness of a public hepatitis C campaign. Fam Pract. 2010;27(3):328\u201332.","journal-title":"Fam Pract"},{"issue":"5","key":"8603_CR16","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.1365-2893.2009.01240.x","volume":"17","author":"G Uddin","year":"2010","unstructured":"Uddin G, Shoeb D, Solaiman S, Marley R, Gore C, Ramsay M, et al. Prevalence of chronic viral hepatitis in people of south asian ethnicity living in England: the prevalence cannot necessarily be predicted from the prevalence in the country of origin. J Viral Hepat. 2010;17(5):327\u201335.","journal-title":"J Viral Hepat"},{"issue":"6","key":"8603_CR17","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1017\/S095026881100152X","volume":"140","author":"H Jafferbhoy","year":"2012","unstructured":"Jafferbhoy H, Miller MH, McIntyre P, Dillon JF. The effectiveness of outreach testing for hepatitis C in an immigrant pakistani population. Epidemiol Infect. 2012;140(6):1048\u201353.","journal-title":"Epidemiol Infect"},{"issue":"4","key":"8603_CR18","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1017\/S0950268811001270","volume":"140","author":"C Richter","year":"2012","unstructured":"Richter C, Beest GT, Sancak I, Aydinly R, Bulbul K, Laetemia-Tomata F, et al. Hepatitis B prevalence in the turkish population of Arnhem: implications for national screening policy? Epidemiol Infect. 2012;140(4):724\u201330.","journal-title":"Epidemiol Infect"},{"issue":"1","key":"8603_CR19","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.2196\/resprot.3822","volume":"4","author":"SS Coughlin","year":"2015","unstructured":"Coughlin SS. Test, listen, cure (TLC) hepatitis C community awareness campaign. JMIR Res Protoc. 2015;4(1):e13.","journal-title":"JMIR Res Protoc"},{"key":"8603_CR20","volume":"12","author":"C Treloar","year":"2015","unstructured":"Treloar C, Newland J, Maher L. A qualitative study trialling the acceptability of new hepatitis C prevention messages for people who inject drugs: symbiotic messages, pleasure and conditional interpretations. Harm Reduct J. 2015;12: 5.","journal-title":"Harm Reduct J"},{"issue":"Suppl 2","key":"8603_CR21","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1177\/00333549161310S205","volume":"131","author":"C Jorgensen","year":"2016","unstructured":"Jorgensen C, Carnes CA, Downs A. Know more Hepatitis: CDC\u2019s National Education Campaign to increase Hepatitis C Testing among People born between 1945 and 1965. Public Health Rep. 2016;131(Suppl 2):29\u201334.","journal-title":"Public Health Rep"},{"issue":"1","key":"8603_CR22","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/QAI.0000000000000930","volume":"72","author":"D Lampkin","year":"2016","unstructured":"Lampkin D, Crawley A, Lopez TP, Mejia CM, Yuen W, Levy V. Reaching suburban men who have sex with men for STD and HIV services through online social networking outreach: a public health approach. J Acquir Immune Defic Syndr 1999. 2016;72(1):73\u20138.","journal-title":"J Acquir Immune Defic Syndr 1999"},{"key":"8603_CR23","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.drugpo.2017.07.022","volume":"47","author":"CW Helsper","year":"2017","unstructured":"Helsper CW, Janssen MP, van Essen GA, Croes EA, van der Veen C, de Wit AG, et al. Effectiveness and cost-effectiveness of nationwide campaigns for awareness and case finding of hepatitis C targeted at people who inject drugs and the general population in the Netherlands. Int J Drug Policy. 2017;47:117\u201325.","journal-title":"Int J Drug Policy"},{"issue":"10","key":"8603_CR24","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S2468-1253(17)30263-7","volume":"2","author":"M Niebel","year":"2017","unstructured":"Niebel M. Living with hepatitis C. Lancet Gastroenterol Hepatol. 2017;2(10):705.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"6","key":"8603_CR25","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1136\/sextrans-2017-053348","volume":"94","author":"M Alarc\u00f3n Guti\u00e9rrez","year":"2018","unstructured":"Alarc\u00f3n Guti\u00e9rrez M, Fern\u00e1ndez Quevedo M, Mart\u00edn Valle S, Jacques-Avi\u00f1\u00f3 C, D\u00edez David E, Cayl\u00e0 JA, et al. Acceptability and effectiveness of using mobile applications to promote HIV and other STI testing among men who have sex with men in Barcelona, Spain. Sex Transm Infect. 2018;94(6):443\u20138.","journal-title":"Sex Transm Infect"},{"issue":"6","key":"8603_CR26","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/j.pec.2018.01.008","volume":"101","author":"T Buller-Taylor","year":"2018","unstructured":"Buller-Taylor T, McGuinness L, Yan M, Janjua NZ. Reducing patient and provider knowledge gaps: an evaluation of a community informed hepatitis C online course. Patient Educ Couns. 2018;101(6):1095\u2013102.","journal-title":"Patient Educ Couns"},{"issue":"S2","key":"8603_CR27","first-page":"186","volume":"25","author":"Eagle","year":"2018","unstructured":"Eagle. Street shot: preventing hepatitis through art. J Viral Hepat. 2018;25(S2):186\u2013186.","journal-title":"J Viral Hepat"},{"issue":"1","key":"8603_CR28","doi-asserted-by":"crossref","DOI":"10.2196\/11291","volume":"21","author":"M Gilbert","year":"2019","unstructured":"Gilbert M, Salway T, Haag D, Kwag M, Edward J, Bondyra M, et al. Assessing the impact of a Social Marketing Campaign on Program Outcomes for users of an internet-based Testing Service for sexually transmitted and blood-borne infections: Observational Study. J Med Internet Res. 2019;21(1): e11291.","journal-title":"J Med Internet Res"},{"issue":"1","key":"8603_CR29","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/jvh.13016","volume":"26","author":"A McLeod","year":"2019","unstructured":"McLeod A, Weir A, Hutchinson SJ, Goldberg DJ. Hepatitis C test uptake among historic blood transfusion recipients following media coverage of the Penrose Inquiry and an awareness-raising campaign. J Viral Hepat. 2019;26(1):93\u2013100.","journal-title":"J Viral Hepat"},{"issue":"5","key":"8603_CR30","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1177\/1524839919833987","volume":"21","author":"A Plant","year":"2020","unstructured":"Plant A, Snow EG, Montoya JA, Young S, Javanbakht M, Klausner JD. Test4HepC: promoting hepatitis C testing to baby boomers using social media. Health Promot Pract. 2020;21(5):780\u201390.","journal-title":"Health Promot Pract"},{"key":"8603_CR31","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2021.103292","volume":"96","author":"TR Broady","year":"2021","unstructured":"Broady TR, Brener L, Vuong T, Cama E, Treloar C. Online interventions to reduce stigma towards population groups affected by blood borne viruses in Australia. Int J Drug Policy. 2021;96: 103292.","journal-title":"Int J Drug Policy"},{"issue":"5","key":"8603_CR32","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1111\/jvh.13486","volume":"28","author":"L Frazzoni","year":"2021","unstructured":"Frazzoni L, Sikandar U, Mazzella G, Fuccio L, Bazzoli F, Brillanti S, et al. A multimedia multilanguage web-based platform can assess and increase the awareness on HCV infection of pakistani people living in Italy. J Viral Hepat. 2021;28(5):764\u201370.","journal-title":"J Viral Hepat"},{"key":"8603_CR33","unstructured":"Hep C. Ki. Available from: https:\/\/hepc.co.uk\/. [Cited 2022 Dec 9]."},{"key":"8603_CR34","unstructured":"Scots with hepatitis C urged. to try new treatments to #BeHepCFree. Available from: https:\/\/sdf.org.uk\/scots-with-hepatitis-c-urged-to-try-new-treatments-to-behepcfree\/. [Cited 2022 Dec 9]."},{"key":"8603_CR35","unstructured":"The Hep C. Trust. The UK vs Europe: losing the fight against hepatitis C. [Grey literature not available online]."},{"key":"8603_CR36","unstructured":"Kunkel J. A review of successful screening campaigns for chronic viral hepatitis in migrant communities in Europe. 2014. Available from: http:\/\/hepscreen.eu\/wp-content\/uploads\/2014\/12\/HEPscreen_review-of-successful-screening-campaigns.pdf."},{"key":"8603_CR37","unstructured":"Liver Institute PLLCA, Communication-Based. Study Focused on Assessing and Improving Hepatitis C Screening Rates, As Well As Treatment Rates in Arizona as a Step Towards Disease Eradication. clinicaltrials.gov; 2021. Report No.: NCT05071261. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT05071261. [Cited 2022 Dec 7]."},{"key":"8603_CR38","unstructured":"Abbvie. Helping to eliminate HCV in Australia by 2030. Available from: https:\/\/www.abbvie.com.au\/content\/dam\/abbvie-dotcom\/au\/documents\/HCV-Elimination-Flyer.pdf. [Cited 2022 Dec 9]."},{"key":"8603_CR39","unstructured":"Hepatitis Victoria. Be Free from Hep C - Hepatitis C treatments community campaign. Available from: https:\/\/na.eventscloud.com\/file_uploads\/c31abfbe99a8b59a2572db0038aaf4d3_122_MelanieEagle.pdf. [Cited 2022 Dec 9]."},{"issue":"1","key":"8603_CR40","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1080\/10810730802592239","volume":"14","author":"SM Noar","year":"2009","unstructured":"Noar SM, Palmgreen P, Chabot M, Dobransky N, Zimmerman RS. A 10-Year systematic review of HIV\/AIDS mass communication campaigns: have we made Progress? J Health Commun. 2009;14(1):15\u201342.","journal-title":"J Health Commun"},{"key":"8603_CR41","doi-asserted-by":"crossref","unstructured":"Durkin S, Wakefield M, Commentary on, Sims et al. (2014) and Langley (2014): Mass media campaigns require adequate and sustained funding to change population health behaviours. Addiction. 2014;109(6):1003\u20134.","DOI":"10.1111\/add.12564"},{"issue":"2","key":"8603_CR42","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1136\/tobaccocontrol-2011-050345","volume":"21","author":"S Durkin","year":"2012","unstructured":"Durkin S, Brennan E, Wakefield M. Mass media campaigns to promote smoking cessation among adults: an integrative review. Tob Control. 2012;21(2):127\u201338.","journal-title":"Tob Control"},{"issue":"3","key":"8603_CR43","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1006\/pmed.2000.0808","volume":"32","author":"DT Levy","year":"2001","unstructured":"Levy DT, Friend K. A computer simulation model of mass media interventions directed at tobacco use. Prev Med. 2001;32(3):284\u201394.","journal-title":"Prev Med"},{"issue":"9748","key":"8603_CR44","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/S0140-6736(10)60809-4","volume":"376","author":"MA Wakefield","year":"2010","unstructured":"Wakefield MA, Loken B, Hornik RC. Use of mass media campaigns to change health behaviour. The Lancet. 2010;376(9748):1261\u201371.","journal-title":"The Lancet"},{"issue":"5","key":"8603_CR45","doi-asserted-by":"crossref","first-page":"916","DOI":"10.2105\/AJPH.2007.117499","volume":"98","author":"J Niederdeppe","year":"2008","unstructured":"Niederdeppe J, Fiore MC, Baker TB, Smith SS. Smoking-Cessation Media Campaigns and their effectiveness among socioeconomically advantaged and disadvantaged populations. Am J Public Health. 2008;98(5):916\u201324.","journal-title":"Am J Public Health"},{"key":"8603_CR46","doi-asserted-by":"crossref","unstructured":"Tellis GJ. Effective advertising: understanding when, how, and why Advertising Works. SAGE Publications; 2003. p. 217.","DOI":"10.4135\/9781452229379"},{"issue":"8","key":"8603_CR47","doi-asserted-by":"crossref","first-page":"e66","DOI":"10.2105\/AJPH.2012.301079","volume":"103","author":"S Dunlop","year":"2013","unstructured":"Dunlop S, Cotter T, Perez D, Wakefield M. Televised antismoking advertising: effects of level and duration of exposure. Am J Public Health. 2013;103(8):e66\u201373.","journal-title":"Am J Public Health"},{"issue":"10","key":"8603_CR48","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1093\/jn\/135.10.2486","volume":"135","author":"J Pomerleau","year":"2005","unstructured":"Pomerleau J, Lock K, Knai C, McKee M. Interventions designed to increase adult fruit and vegetable intake can be effective: a systematic review of the literature. J Nutr. 2005;135(10):2486\u201395.","journal-title":"J Nutr"},{"issue":"7","key":"8603_CR49","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1038\/ijo.2008.79","volume":"32","author":"AM Sanigorski","year":"2008","unstructured":"Sanigorski AM, Bell AC, Kremer PJ, Cuttler R, Swinburn BA. Reducing unhealthy weight gain in children through community capacity-building: results of a quasi-experimental intervention program, be active eat well. Int J Obes. 2008;32(7):1060\u20137.","journal-title":"Int J Obes"},{"issue":"8","key":"8603_CR50","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1080\/02640410410001712467","volume":"22","author":"N Cavill","year":"2004","unstructured":"Cavill N, Bauman A. Changing the way people think about health-enhancing physical activity: do mass media campaigns have a role? J Sports Sci. 2004;22(8):771\u201390.","journal-title":"J Sports Sci"},{"issue":"2","key":"8603_CR51","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ypmed.2004.04.018","volume":"40","author":"SJ Finlay","year":"2005","unstructured":"Finlay SJ, Faulkner G. Physical activity promotion through the mass media: Inception, production, transmission and consumption. Prev Med. 2005;40(2):121\u201330.","journal-title":"Prev Med"},{"issue":"6","key":"8603_CR52","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1111\/add.12448","volume":"109","author":"T Langley","year":"2014","unstructured":"Langley T, Szatkowski L, Lewis S, McNeill A, Gilmore AB, Salway R, et al. The freeze on mass media campaigns in England: a natural experiment of the impact of tobacco control campaigns on quitting behaviour. Addiction. 2014;109(6):995\u20131002.","journal-title":"Addiction"},{"issue":"1","key":"8603_CR53","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.amepre.2004.03.002","volume":"27","author":"RW Elder","year":"2004","unstructured":"Elder RW, Shults RA, Sleet DA, Nichols JL, Thompson RS, Rajab W. Effectiveness of mass media campaigns for reducing drinking and driving and alcohol-involved crashes: a systematic review. Am J Prev Med. 2004;27(1):57\u201365.","journal-title":"Am J Prev Med"},{"issue":"1","key":"8603_CR54","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0022-4375(95)00027-5","volume":"27","author":"AF Williams","year":"1996","unstructured":"Williams AF, Reinfurt D, Wells JK. Increasing seat belt use in North Carolina. J Saf Res. 1996;27(1):33\u201341.","journal-title":"J Saf Res"},{"key":"8603_CR55","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ypmed.2013.12.001","volume":"60","author":"CP Cooper","year":"2014","unstructured":"Cooper CP, Gelb CA, Hawkins NA. How many get screened messages does it take? Evidence from colorectal cancer screening promotion in the United States, 2012. Prev Med. 2014;60:27\u201332.","journal-title":"Prev Med"},{"issue":"1","key":"8603_CR56","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-024267","volume":"9","author":"SJ Durkin","year":"2019","unstructured":"Durkin SJ, Broun K, Spittal MJ, Wakefield MA. Impact of a mass media campaign on participation rates in a national bowel cancer screening program: a field experiment. BMJ Open. 2019;9(1): e024267.","journal-title":"BMJ Open"},{"issue":"6","key":"8603_CR57","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1111\/add.12501","volume":"109","author":"M Sims","year":"2014","unstructured":"Sims M, Salway R, Langley T, Lewis S, McNeill A, Szatkowski L, et al. Effectiveness of tobacco control television advertising in changing tobacco use in England: a population-based cross-sectional study. Addiction. 2014;109(6):986\u201394.","journal-title":"Addiction"},{"issue":"6","key":"8603_CR58","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1093\/her\/cyr054","volume":"26","author":"MA Wakefield","year":"2011","unstructured":"Wakefield MA, Spittal MJ, Yong HH, Durkin SJ, Borland R. Effects of mass media campaign exposure intensity and durability on quit attempts in a population-based cohort study. Health Educ Res. 2011;26(6):988\u201397.","journal-title":"Health Educ Res"},{"issue":"2","key":"8603_CR59","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.amepre.2007.09.024","volume":"34","author":"SJ Dobbinson","year":"2008","unstructured":"Dobbinson SJ, Wakefield MA, Jamsen KM, Herd NL, Spittal MJ, Lipscomb JE, et al. Weekend sun protection and sunburn in Australia: trends (1987\u20132002) and association with sunsmart television advertising. Am J Prev Med. 2008;34(2):94\u2013101.","journal-title":"Am J Prev Med"},{"key":"8603_CR60","volume-title":"Public Health communication","author":"S Zimicki","year":"2002","unstructured":"Zimicki S, Hornik RC, Verzosa CC, Hernandez JR, de Guzman E, Dayrit M, et al. Improving Vaccination Coverage in Urban Areas through a Health communication campaign: the 1990 Philippines experience. In: Public Health communication. Routledge; 2002."},{"key":"8603_CR61","doi-asserted-by":"crossref","DOI":"10.4324\/9781410603029","volume-title":"Public Health Communication","author":"RC Hornik","year":"2002","unstructured":"Hornik RC, McDivitt J, Zimicki S, Yoder PS, Contreras-Budge E, McDowell J, et al. Communication in support of child survival: evidence and explanations from eight countries. In: Public Health Communication. Routledge; 2002."},{"key":"8603_CR62","unstructured":"Davis RM. The role of the media in promoting and reducing Tobacco Use. U.S. Department of Health and Human Services, National Institutes of Health, National Cancer Institute; 2008. p. 692."},{"issue":"5","key":"8603_CR63","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1007\/BF03404575","volume":"93","author":"ME Black","year":"2002","unstructured":"Black ME, Yamada J, Mann V. A systematic literature review of the effectiveness of communitybased strategies to increase cervical Cancer screening. Can J Public Health. 2002;93(5):386\u201393.","journal-title":"Can J Public Health"},{"issue":"12","key":"8603_CR64","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.2105\/AJPH.2009.161638","volume":"99","author":"SJ Durkin","year":"2009","unstructured":"Durkin SJ, Biener L, Wakefield MA. Effects of different types of antismoking ads on reducing disparities in smoking cessation among socioeconomic subgroups. Am J Public Health. 2009;99(12):2217\u201323.","journal-title":"Am J Public Health"},{"issue":"3","key":"8603_CR65","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1093\/her\/cym021","volume":"23","author":"R Mullins","year":"2008","unstructured":"Mullins R, Wakefield M, Broun K. Encouraging the right women to attend for cervical cancer screening: results from a targeted television campaign in Victoria, Australia. Health Educ Res. 2008;23(3):477\u201386.","journal-title":"Health Educ Res"},{"issue":"6","key":"8603_CR66","doi-asserted-by":"crossref","first-page":"901","DOI":"10.2105\/AJPH.92.6.901","volume":"92","author":"MC Farrelly","year":"2002","unstructured":"Farrelly MC, Healton CG, Davis KC, Messeri P, Hersey JC, Haviland ML. Getting to the truth: evaluating national tobacco countermarketing campaigns. Am J Public Health. 2002;92(6):901\u20137.","journal-title":"Am J Public Health"},{"issue":"12","key":"8603_CR67","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.2105\/AJPH.2005.083352","volume":"96","author":"M Wakefield","year":"2006","unstructured":"Wakefield M, Terry-McElrath Y, Emery S, Saffer H, Chaloupka FJ, Szczypka G, et al. Effect of Televised, tobacco company\u2013funded smoking prevention advertising on youth smoking-related beliefs, intentions, and behavior. Am J Public Health. 2006;96(12):2154\u201360.","journal-title":"Am J Public Health"},{"issue":"1","key":"8603_CR68","first-page":"1","volume":"20","author":"SW Smith","year":"2006","unstructured":"Smith SW, Atkin CK, Roznowski J. Are drink responsibly. Alcohol Campaigns Strategically Ambiguous? Health Commun. 2006;20(1):1\u201311.","journal-title":"Alcohol Campaigns Strategically Ambiguous? Health Commun"},{"key":"8603_CR69","unstructured":"Don\u2019t Live in Doubt. - treatment for hepatitis C in Leeds. 2019. Available from: https:\/\/www.youtube.com\/watch?v=Bca92_v1-60. [Cited 2022 Dec 9]."},{"issue":"S5","key":"8603_CR70","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1002\/cncr.20508","volume":"101","author":"RJ Pasick","year":"2004","unstructured":"Pasick RJ, Hiatt RA, Paskett ED. Lessons learned from community-based cancer screening intervention research. Cancer. 2004;101(S5):1146\u201364.","journal-title":"Cancer"},{"issue":"1, Supplement","key":"8603_CR71","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.amepre.2008.04.002","volume":"35","author":"RC Baron","year":"2008","unstructured":"Baron RC, Rimer BK, Breslow RA, Coates RJ, Kerner J, Melillo S, et al. Client-Directed interventions to increase community demand for breast, cervical, and colorectal cancer screening: a systematic review. Am J Prev Med. 2008;35(1, Supplement):34\u201355.","journal-title":"Am J Prev Med"},{"key":"8603_CR72","unstructured":"Croxford S, Emanuel E, Ibitoye A, Njoroge J, Edmundson C. Changes to the provision of services for people who inject drugs in England, Wales and Northern Ireland during the COVID-19 pandemic. In Virtual; 2021. Available from: https:\/\/region-hovedstaden-ekstern.23video.com\/po2-1-croxfordmp4mp4."},{"key":"8603_CR73","unstructured":"UKHSA. Shooting Up: infections and other injecting-related harms among people who inject drugs in the UK., 2020. 2021. Available from: https:\/\/www.gov.uk\/government\/publications\/shooting-up-infections-among-people-who-inject-drugs-in-the-uk."},{"key":"8603_CR74","unstructured":"Armstrong G, Adam S, Denize S, Kotler P. Principles of Marketing Pearson Australia; 2014. p. 601."},{"key":"8603_CR75","unstructured":"Wellings K. Evaluating AIDS public education in Europe: a cross-national comparison. In: Hornik RC, editor. Public Health Communication: Evidence for Behavior Change. Lawrence Erlbaum Associates; 2002. p. 131\u201346. https:\/\/researchonline.lshtm.ac.uk\/id\/eprint\/18062."}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-023-08603-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-023-08603-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-023-08603-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,22]],"date-time":"2023-11-22T08:06:42Z","timestamp":1700640402000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-023-08603-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,26]]},"references-count":75,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["8603"],"URL":"https:\/\/doi.org\/10.1186\/s12879-023-08603-3","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,26]]},"assertion":[{"value":"11 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"CS has received funding for membership of Advisory Boards, Data Safety and Monitoring Panels and for the preparation of educational materials from Gilead Sciences, ViiV Healthcare, Janssen-Cilag and MSD. All other authors declare no competing risks.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"629"}}